BARITUSSIO, ALDO
 Distribuzione geografica
Continente #
NA - Nord America 5.220
AS - Asia 603
EU - Europa 522
OC - Oceania 4
AF - Africa 3
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.355
Nazione #
US - Stati Uniti d'America 5.214
CN - Cina 366
SG - Singapore 178
FI - Finlandia 118
IT - Italia 105
DE - Germania 85
UA - Ucraina 66
FR - Francia 49
SE - Svezia 49
GB - Regno Unito 34
VN - Vietnam 34
IN - India 12
HK - Hong Kong 8
IE - Irlanda 6
IR - Iran 5
AU - Australia 4
CA - Canada 4
NL - Olanda 4
RO - Romania 3
ZA - Sudafrica 3
BE - Belgio 1
BG - Bulgaria 1
BR - Brasile 1
BZ - Belize 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EU - Europa 1
VE - Venezuela 1
Totale 6.355
Città #
Fairfield 843
Woodbridge 481
Houston 432
Chandler 377
Ann Arbor 371
Ashburn 348
Seattle 326
Wilmington 318
Jacksonville 312
Cambridge 292
Singapore 138
Boardman 123
Princeton 123
San Diego 98
Beijing 93
Roxbury 71
Des Moines 68
Nanjing 51
Medford 50
Helsinki 44
Santa Clara 44
Dong Ket 34
Padova 29
Guangzhou 22
Nanchang 21
Hebei 16
Shenyang 16
Changsha 15
Hefei 12
Jinan 10
Tianjin 9
London 8
Norwalk 8
Washington 8
Falls Church 7
Jiaxing 7
Dublin 6
Hong Kong 6
Bologna 5
Kharkiv 5
Milan 5
Redwood City 5
Dallas 4
Fuzhou 4
Haikou 4
Kunming 4
Shanghai 4
Tappahannock 4
Vicenza 4
Acworth 3
Catania 3
Dearborn 3
Detroit 3
Hangzhou 3
Johannesburg 3
Kilburn 3
Lanzhou 3
New York 3
Ningbo 3
Bengaluru 2
Birmingham 2
Boulder 2
Cassola 2
Falkenstein 2
Frankfurt am Main 2
Irvine 2
Livingston 2
Mestre 2
Munich 2
Ogden 2
Redmond 2
Schio 2
Shaoxing 2
Taiyuan 2
Taizhou 2
Toronto 2
Adelaide 1
Andover 1
Baltimore 1
Baoding 1
Barquisimeto 1
Belize City 1
Belo Horizonte 1
Bolton 1
Camponogara 1
Camposampiero 1
Castelnuovo Rangone 1
Cento 1
Central 1
Chengdu 1
Chennai 1
Chicago 1
Chiswick 1
Dharwad 1
Florence 1
Frankfurt (Oder) 1
Groningen 1
Hounslow 1
Iasi 1
Islington 1
Totale 5.373
Nome #
Simultaneous measurement of phosphatidylglycerol and disaturated-phosphatidylcholine palmitate kinetics from alveolar surfactant. Study in infants with stable isotope tracer, coupled with isotope ratio mass spectrometry. 198
Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process 170
Surfactant disaturated-phosphatidylcholine kinetics in acute respiratory distress syndrome by stable isotopes and a two compartment model 149
Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes 149
Disaturated-phosphatidylcholine and Surfactant protein-B turnover in human acute lung injury and in control patients 148
Amiodarone impairs trafficking through late endosomes inducing a Niemann-Pick C-like phenotype 136
The life cycle of a low-molecular-weight protein of surfactant (SP-C) in 3-day-old rabbits. 130
SP-A binds alpha(1)-antitrypsin in vitro and reduces the association rate constant for neutrophil elastase 129
Amiodarone Alters Late Endosomes and Inhibits SARS Coronavirus Infection at a Post Endosomal Level 125
SP-A, SP-B, and SP-C in surfactant subtypes around birth: reexamination of alveolar life cycle of surfactant. 123
Antiviral activity of cationic amphiphilic drugs 122
Surfactant protein B amount and kinetics in newborn infants: an optimized procedure. 110
Dosing of Porcine Surfactant: Effect on Kinetics and Gas Exchange in Respiratory Distress Syndrome 107
Surfactant Proteins A and B (sp-a and Sp-b) In Bronchoalveolar Lavages of Children With Chronic Lung Disease 107
Effects of metabolites and analogs of amiodarone on alveolar macrophages: structure-activity relationship 106
Synthesis and cytotoxicity properties of amiodarone analogues. 104
Alcohol induced burr cell (echinocytic) haemolytic anaemia and haemochromatosis. 104
Bronchoalveolar lavage fluid composition in alveolar proteinosis. Early changes after therapeutic lavage 103
Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report 103
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010. 102
Acute effects of pulmonary artery occlusion on the pool of alveolar surfactant. 101
Amiodarone inhibits lung degradation of SP-A and perturbs the distribution of lysosomal enzymes 100
Surfactant protein B and A concentrations are increased in neonatal pneumonia 97
Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy 97
The use of degrees of certainty to evaluate knowledge 96
Altered surfactant synthesis and function in rats with diet-induced hyperlipidemia. 95
Amiodarone increases positive-strand RNA virus replication in vitro: implications for its use in patients with viral infections 93
Surfactant-associated protein B kinetics in vivo in newborn infants by stable isotopes 90
Risk factors for hospital readmission of elderly patients. 88
Mediastino-abdominal lipomatosis: deep accumulation of fat mimicking a respiratory disease and ascites. Clinical aspects and metabolic studies in vitro 87
Effect of anorexiant drugs on growth hormone secretion in obese children. 86
Surfactant protein C metabolism in human infants and adult patients by stable isotope tracer and mass spectrometry. 86
Influence of the type of congenital heart defects on epithelial lining fluid composition in infants undergoing cardiac surgery with cardiopulmonary bypass 85
Antiviral Properties of Amiodarone: More than a Pleyotropic Effect. 84
Surfactant synthesis and kinetics in infants with congenital diaphragmatic hernia 82
Impaired surfactant protein b synthesis in infants with congenital diaphragmatic hernia. 82
Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life. 82
Postnatal transformations of alveolar surfactant in the rabbit: changes in pool size, pool morphology and isoforms of the 32-38 kDa apolipoprotein. 81
Effects of fat mass reduction by dieting and by lipectomy on carbohydrate metabolism in obese patients. 80
Educating diabetic patients about insulin use: changes over time in certainty and correctness of knowledge. 80
Short-term and long-term clinical evaluation of a non-amphetaminic anorexiant (mazindol) in the treatment of obesity. 79
Antioxidant defences of rabbit alveolar lining fluid. 79
Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa? 77
Different pathways of degradation of SP-A and saturated phosphatidylcholine by alveolar macrophages. 77
Turnover of phospholipids isolated from fractions of lung lavage fluid. 76
Cloning, expression, purification and characterization of Streptococcus pneumoniae IgA1 protease. 75
Adipose tissue development "in utero". Relationships between some nutritional and hormonal factors and body fat mass enlargement in newborns. 72
Subfractionation of lung surfactant. Implications for metabolism and surface activity. 71
In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine 70
Effects of amiodarone on HSV-1 replication cycle: a new antiviral treatment? 69
Multiple symmetric lipomatosis: a defect in adrenergic-stimulated lipolysis. 69
In chyloptysis, SP-A affects the clearance of serum lipoproteins entering the airways. 65
Ventilation enhances pulmonary alveolar clearance of radioactive dipalmitoyl phosphatidylcholine in liposomes. 63
Heterogeneity of alveolar surfactant in the rabbit: composition, morphology, and labelling of subfractions isolated by centrifugation of lung lavage. 61
Serum of normal subjects contains IgG with antibody-like specificity for phospholipids. 60
Amiodarone affects Ebola virus binding and entry into target cells 60
Amiodarone inhibits Ebola virus infection by Blocking Viral Entry Into Target Cells Through Late Endosomes 59
LA PROTEINOSI ALVEOLARE CONGENITA 58
Effects of amiodarone on HSV-1 replication cycle 57
Amiodarone inhibits Ebola virus replication in vitro 54
Uptake and degradation of Curosurf after tracheal administration to newborn and adult rabbits. 52
INFLUENCE OF TYPE OF CONGENITAL HEART DEFECTS ON EPITHELIAL LINING FLUID COMPOSITION IN INFANTS UNDERGOING CARDIAC SURGERY WITH CARDIOPULMONARY-BYPASS 52
Colesterolo di membrana e difese antiinfettive. Implicazioni per la patogenesi della tubercolosi 51
Mechanisms of amiodarone lung toxicity 51
Heparin, cartopril and dermatansulphate are ineffective in preventing bleomycin-induced lung fibrosis in rats. 50
Metabolic abnormalities in multiple symmetric lipomatosis: elevated lipoprotein lipase activity in adipose tissue with hyperalphalipoproteinemia. 50
Uso di amiodarone e suoi analoghi come agenti antivirali 46
Use of amiodarone and amiodarone analogues as antiviral agents 46
Trattato di Medicina Interna 44
La proteinosi alveolare 41
Outcomes of patients hospitalized withcommunity-acquired, health care-associated, and hospital-acquired pneumonia. 39
Precursor-product relationship between rabbit type II cell lamellar bodies and alveolar surface-active material. Surfactant turnover time. 39
Surfactant disaturated phosphatidylcholine kinetics in human adults with acute respiratory distress syndrome using stable isotopes. 38
Gli elementi traccia: fisiologia e clinica 35
Surfactant apoprotein A modulates interleukin-8 and monocyte chemotactic peptide-1 production. 35
Nonspecific interstitial pneumonia, alveolar proteinosis, and abnormal trafficking resulting from a spontaneous mutation of surfactant protein C gene 34
Pathogenesis of black pigment gallstones in a hamster model. 30
Lung surfactant, asthma and allergens. A story in evolution. 19
Totale 6.400
Categoria #
all - tutte 21.052
article - articoli 18.694
book - libri 538
conference - conferenze 0
curatela - curatele 0
other - altro 172
patent - brevetti 283
selected - selezionate 0
volume - volumi 141
Totale 40.880


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.027 0 0 0 0 131 97 181 157 152 173 63 73
2020/20211.032 33 158 34 73 50 110 24 80 149 102 128 91
2021/2022985 25 125 130 58 36 52 67 68 50 19 131 224
2022/2023793 166 92 6 89 144 115 7 49 87 2 28 8
2023/2024370 7 42 55 35 47 36 33 11 7 8 41 48
2024/2025451 9 87 82 75 198 0 0 0 0 0 0 0
Totale 6.400